Verity Asset Management, Inc. Catalyst Biosciences, Inc. Transaction History

Verity Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$4.93 - $7.15 $133,341 - $193,386	-27,047 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$4.55 - $7.29 $123,063 - $197,172	27,047 New	27,047 $171,000
Q3 2020 Nov 13, 2020	SELL	$4.22 - $6.04 $65,570 - $93,849	-15,538 Closed	0 $0
Q2 2020 Nov 13, 2020	SELL	$3.76 - $8.01 $11,170 - $23,797	-2,971 Reduced 16.05%	15,538 $91,000
Q1 2020 May 18, 2020	BUY	$3.5 - $8.51 $64,781 - $157,511	18,509 New	18,509 $81,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Verity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Verity Asset Management, Inc. with notifications on news.